Managing Neurological Rehabilitation

• What is the neurological diagnosis and date of onset (acute vs. chronic)?
• What is the lesion location and laterality (e.g., L MCA CVA, C5 SCI, R basal ganglia hemorrhage)?
• What is the current NIHSS score (stroke) or equivalent severity measure?
• What is the cognitive status (orientation, command-following, safety awareness)?
• Are there medical comorbidities affecting rehab intensity (cardiac, respiratory, diabetes)?
• What medications affect neurological examination (antispasmodics, anticonvulsants, sedatives)?

Required documents:

• Neuroimaging reports (CT, MRI) with lesion characterization
• Acute care discharge summary with neurological examination
• Current medication list with neuroactive drugs identified
• FIM scores at admission (or most recent if in progress)
• Prior functional status documentation (PLOF)
• Physician orders including therapy disciplines, frequency, and precautions

Step 1 — Classify Neurological Status Using Standardized Scales

For stroke patients:

• NIHSS (National Institutes of Health Stroke Scale): 0-42 point scale; score at admission and track serially
  • 0-4: Minor stroke
  • 5-15: Moderate stroke
  • 16-20: Moderate-to-severe stroke
  • 21-42: Severe stroke
• Brunnstrom stages of motor recovery (1-7):
  • Stage 1: Flaccidity, no voluntary movement
  • Stage 2: Emerging spasticity, synergy patterns appearing
  • Stage 3: Spasticity peaks, voluntary movement only in synergy
  • Stage 4: Spasticity declining, some movement outside synergy
  • Stage 5: Isolated joint movements, spasticity waning
  • Stage 6: Individual joint movements with coordination, no spasticity
  • Stage 7: Normal motor function

For spasticity:

• Modified Ashworth Scale (MAS):
  • 0: No increase in tone
  • 1: Slight increase, catch-and-release at end of ROM
  • 1+: Slight increase, catch then minimal resistance through <50% ROM
  • 2: More marked increase through most of ROM, limb easily moved
  • 3: Considerable increase, passive movement difficult
  • 4: Rigid in flexion or extension

For all neuro patients:

• FIM (Functional Independence Measure): 18-item, 7-level scale; total 18-126; motor subscale 13-91, cognitive subscale 5-35
• Barthel Index: 10-item ADL scale, 0-100 (0 = fully dependent, 100 = independent)

Step 2 — Establish Motor Recovery Stage and Prognosis

Document current motor recovery status and expected trajectory:

Stroke prognosis indicators:

• Severe initial UE hemiplegia (no finger extension by 4 weeks): <15% chance of functional hand recovery
• Presence of shoulder subluxation: correlates with poorer UE outcome
• Early return of voluntary finger extension: strongest predictor of UE recovery
• Independent sitting balance within first week: positive prognostic indicator for ambulation
• FIM admission score: strongest predictor of FIM gain and discharge FIM

Recovery timelines (general):

• Most rapid neurological recovery: first 3 months post-stroke
• Maximum motor recovery: typically reached by 6 months
• Functional gains may continue 12+ months through compensatory strategies
• Spasticity onset: typically 1-6 weeks post-stroke, peaks 1-3 months

For Parkinson disease: Use Hoehn & Yahr staging (1-5) and Unified Parkinson Disease Rating Scale (UPDRS). Document ON/OFF medication state during all testing.

For MS: Use Expanded Disability Status Scale (EDSS, 0-10) and document relapsing vs. progressive course.

Step 3 — Design Neuroplasticity-Based Intervention Program

Apply evidence-based neurorehabilitation principles:

Intensity and dosing:

• Task-specific repetition: minimum 300-400 repetitions per session for motor learning (EXCITE trial evidence)
• IRF requirement: 3 hours/day minimum across disciplines, 5 days/week
• Constraint-induced movement therapy (CIMT): 6 hours/day for 2 weeks (modified protocols: 2-3 hours/day)
• Locomotor training (body-weight supported treadmill): 30-60 minutes per session, 5 days/week

Intervention selection by recovery stage:

Spasticity management integration:

• Positioning and splinting program documented with wearing schedule
• Botulinum toxin timing: coordinate with MD; therapy intensified 2-4 weeks post-injection for maximum benefit
• Intrathecal baclofen: document pump settings and functional response
• Serial casting: protocol duration (typically changed every 5-7 days for 3-4 weeks)

Step 4 — Track Recovery with Serial Standardized Assessments

Assessment schedule:

• FIM: admission, weekly team conference, discharge (minimum); IRF-PAI requires specific timeframes
• NIHSS: admission, day 7, day 30, and significant change events
• Modified Ashworth: each reassessment for patients with spasticity
• Berg Balance Scale: admission, bi-weekly, discharge
• 6MWT and 10MWT: when ambulatory, bi-weekly for progress tracking
• Cognitive screens (MoCA, MMSE): admission, monthly, discharge

FIM efficiency tracking:

• FIM efficiency = FIM gain ÷ Length of stay (days)
• National average FIM efficiency for stroke: approximately 1.5-2.0 points/day
• FIM efficiency below 1.0 should trigger team conference to evaluate barriers
• Track motor and cognitive subscales separately to identify specific deficits

Step 5 — Coordinate Interdisciplinary Team Conference Documentation

Neurorehab requires formal interdisciplinary coordination:

• Team members: Physiatrist, PT, OT, SLP, rehabilitation nursing, neuropsychology, case management, social work
• Conference frequency: Weekly minimum for IRF; document attendees, patient discussed, and decisions
• Required documentation per conference:
  • Current FIM scores by discipline
  • Progress toward short-term and long-term goals
  • Barriers to progress (medical, cognitive, psychosocial)
  • Projected discharge date and disposition
  • Family training status and discharge planning needs
  • Any goal modifications with clinical rationale

Checkpoint B — Pre-Finalization Review

Before finalizing neurological rehabilitation documentation:

• Neurological diagnosis with lesion location and date of onset documented
• All standardized scales scored and dated (NIHSS, FIM, MAS, Brunnstrom)
• Motor recovery stage and prognosis documented with supporting evidence
• Intervention program reflects neuroplasticity principles with dosing parameters
• Spasticity management plan integrated with therapy schedule
• Serial assessment schedule established and tracked
• Team conference documentation complete with all required elements
• Discharge planning initiated with projected date and disposition
• Patient/family education and training documented
• All [VERIFY] flags resolved

Quality Audit

• NIHSS scored correctly with all 15 items documented
• FIM scores reflect observed performance, not patient report
• Modified Ashworth Scale specifies joint, direction, and velocity of stretch
• Brunnstrom stage documented for UE, hand, and LE separately
• Intervention dosing (repetitions, time, intensity) documented per session
• Recovery trajectory compared to evidence-based timelines
• FIM efficiency calculated and compared to national benchmarks
• Medications affecting neurological exam documented
• Team conference notes signed by all disciplines present
• Documentation meets IRF-PAI, CMS, and CARF requirements

Guidelines

• All neuro patients in IRF must meet the 60% rule: primary diagnosis must be one of the 13 CMS-specified conditions
• FIM scoring requires credentialed raters — verify examiner certification status
• Do not confuse Brunnstrom stages with MRC strength grades — they measure different constructs
• Spasticity is velocity-dependent — document speed of passive stretch during MAS testing
• CIMT is contraindicated for patients without minimum 10 degrees active wrist extension and 10 degrees active finger extension
• Cognitive deficits (neglect, aphasia, executive dysfunction) significantly impact motor rehabilitation potential — always assess and document
• Neurological recovery is not linear — plateaus are expected; document continued skilled need through intervention modification
• Early mobilization within 24-48 hours post-stroke is evidence-based; delayed mobilization requires documented medical justification
• Serial documentation must use the same instruments, same conditions, and ideally same examiner for valid comparison
• Escalate to the physiatrist when recovery trajectory deviates significantly from expected, new neurological symptoms emerge, or spasticity is not responding to conservative management